يعرض 1 - 20 نتائج من 62 نتيجة بحث عن '"Rajesh K. Malik"', وقت الاستعلام: 0.55s تنقيح النتائج
  1. 1
    Academic Journal
    Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

    المؤلفون: Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García‐Campelo, William Edenfield, Trevor M. Feinstein, Jennifer M. Johnson, Sujith Kalmadi, Philip E. Lammers, Alfredo Sanchez‐Hernandez, Yili Pritchett, Shannon R. Morris, Rajesh K. Malik, Tibor Csőszi

    المصدر: Cancer Medicine, Vol 10, Iss 17, Pp 5748-5756 (2021)

    مصطلحات موضوعية: anemia, erythropoiesis‐stimulating agent, granulocyte colony‐stimulating factor, neutropenia, red blood cell transfusion, trilaciclib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/2045-7634

    URL الوصول: https://doaj.org/article/67201ebc01a245ac809c92ab296cf9ee

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Academic Journal
    CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

    المؤلفون: Zhao Yang, Taofeek K Owonikoko, Konstantin H Dragnev, Anne Y Lai, Jessica A Sorrentino, Jared M Weiss, Julie A Rytlewski, Jill Hood, Rajesh K Malik, Jay C Strum, Patrick J Roberts

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://jitc.bmj.com/content/8/2/e000847.full; https://doaj.org/toc/2051-1426

    URL الوصول: https://doaj.org/article/69e813bd7bb34caeaa699ef0d1860007

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  3. 3
    Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

    المؤلفون: Rajesh K. Malik, Yili Pritchett, Jennifer Johnson, Balazs Medgyasszay, Shannon R. Morris, Renata Ferrarotto, Trevor M. Feinstein, William Jeffery Edenfield, Maria Rosario García-Campelo, Ian Anderson, Tibor Csőszi, Alfredo Sanchez-Hernandez, Sujith Kalmadi, Philip E. Lammers

    المصدر: Cancer Medicine
    Cancer Medicine, Vol 10, Iss 17, Pp 5748-5756 (2021)

    مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Neutropenia, Anemia, medicine.drug_class, medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, Placebo, granulocyte colony‐stimulating factor, Double-Blind Method, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Pyrroles, red blood cell transfusion, RC254-282, Research Articles, Randomized Controlled Trials as Topic, Retrospective Studies, Myelosuppressive Chemotherapy, Chemotherapy, trilaciclib, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Clinical Cancer Research, medicine.disease, Erythropoiesis-stimulating agent, anemia, Small Cell Lung Carcinoma, erythropoiesis‐stimulating agent, Granulocyte colony-stimulating factor, Pyrimidines, Oncology, Female, business, Research Article

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02186969879d8ae63ae2a1d68491ab2f
    http://europepmc.org/articles/PMC8419768

    View record in OpenAIRE

    أضف إلى المفضلة
  4. 4
    Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer

    المؤلفون: Manuel Dómine Gómez, Tibor Csőszi, Rajesh K. Malik, Krasimir Nikolov, Iveta Kudaba, Davorin Radosavljevic, Jana Jaal, Janet K. Horton, Jie Xiao, Janakiraman Subramanian

    المصدر: International Journal of Cancer

    مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Placebo, chemotherapy, Double-Blind Method, Internal medicine, medicine, Humans, Cumulative incidence, Myeloid Cells, Pyrroles, Prospective Studies, myelopreservation, Cancer Therapy and Prevention, Etoposide, Aged, myelosuppression, Chemotherapy, Myelosuppressive Chemotherapy, trilaciclib, business.industry, Middle Aged, medicine.disease, Prognosis, Chemotherapy regimen, Hematologic Diseases, Small Cell Lung Carcinoma, Pyrimidines, Cytoprotection, Toxicity, Female, small cell lung cancer, business, myeloprotection, Febrile neutropenia, medicine.drug, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397a1ab260b5397a4563aa20f7c067be
    http://europepmc.org/articles/PMC8457063

    View record in OpenAIRE

    أضف إلى المفضلة
  5. 5
    Abstract PS12-04: Rintodestrant (G1T48), an oral selective estrogen receptor degrader in ER+/HER2- locally advanced or metastatic breast cancer: Updated phase 1 results and dose selection

    المؤلفون: Carolien P. Schröder, Mark D. Pegram, Ramsha Iqbal, Jorianne Boers, Agnes Jager, Marina Maglakelidze, Linnea Chap, Catharina W Menke-van der Houven van Oordt, Susanna Varkey Ulahannan, E. Claire Dees, Adrian Crijanovschi, Wenli Tao, Christina Sipes, Iurie Bulat, Curt Douglas Wolfgang, Philippe Aftimos, Rajesh K. Malik, Patrick Neven, Massimo Cristofanilli, Erika Hamilton, Sarika Jain

    المصدر: Cancer Research. 81:PS12-04

    مصطلحات موضوعية: Cancer Research, education.field_of_study, medicine.medical_specialty, Fulvestrant, business.industry, Population, Estrogen receptor, Cancer, Palbociclib, medicine.disease, Metastatic breast cancer, Gastroenterology, Breast cancer, Oncology, Tolerability, Internal medicine, medicine, education, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6703b9b62640f85b7b3a606be97597fa
    https://doi.org/10.1158/1538-7445.sabcs20-ps12-04

    View record in OpenAIRE

    أضف إلى المفضلة
  6. 6
    Abstract P1-19-17: Dose escalation and expansion study of lerociclib (G1T38), an oral CDK4/6 inhibitor, dosed with no drug holiday in combination with fulvestrant in patients with HR+/HER2- advanced breast cancer

    المؤلفون: Maia Gogiladze, Amy McCullough, Andrew M Wardley, Chao Li, Boris Krastev, Andrew P. Beelen, Marina Maglakelidze, Rajesh K. Malik, Iurie Bulat, Yili Pritchett, Richard D. Baird, C. Murias, Jessica A. Sorrentino, Adrian Crijanovschi, R Roylance

    المصدر: Cancer Research. 80:P1-19

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, education.field_of_study, Fulvestrant, business.industry, Population, Drug holiday, Neutropenia, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, Tolerability, 030220 oncology & carcinogenesis, Internal medicine, medicine, Progression-free survival, education, Adverse effect, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::37e874a72ee4c6450338cb30df6364c7
    https://doi.org/10.1158/1538-7445.sabcs19-p1-19-17

    View record in OpenAIRE

    أضف إلى المفضلة
  7. 7
    Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies

    المؤلفون: Donald A. Richards, J. Thaddeus Beck, Rajesh K. Malik, Joyce M Antal, Ivan Sinielnikov, Keith Lerro, Marielle Sabatini, Maen A. Hussein, Marina Maglakelidze, Alexander I. Spira, Todd A Gersten, Yili Pritchett

    المصدر: Cancer Management and Research

    مصطلحات موضوعية: myelosuppression, Chemotherapy, medicine.medical_specialty, trilaciclib, business.industry, Anemia, medicine.medical_treatment, Incidence (epidemiology), Subgroup analysis, Placebo, medicine.disease, chemotherapy, Clinical trial, Oncology, Cancer Management and Research, Internal medicine, medicine, Patient-reported outcome, small cell lung cancer, myelopreservation, business, myeloprotection, Febrile neutropenia, Original Research

    وصف الملف: text/html

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302a79f6b1f9ddbdbd908703851c2717
    https://www.dovepress.com/myeloprotective-effects-of-trilaciclib-among-patients-with-small-cell--peer-reviewed-fulltext-article-CMAR

    View record in OpenAIRE

    أضف إلى المفضلة
  8. 8
    Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer

    المؤلفون: Chao Li, Paul Conkling, Raid Aljumaily, Caio Max Sao Pedro Rocha Lima, William Jeffery Edenfield, Lowell L. Hart, Steven R. Schuster, Deborah A. Smith, Rajesh K. Malik, Jessica A. Sorrentino, Patrick J. Roberts, Taofeek K. Owonikoko, Roy Timothy Webb, Robert M. Jotte, Mark Sale

    المصدر: Cancer Chemotherapy and Pharmacology

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Cell cycle checkpoint, Lung Neoplasms, Adolescent, Toxicology, CDK4/6 inhibitor, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pharmacokinetics, Internal medicine, medicine, Trilaciclib, Humans, Pharmacology (medical), Pyrroles, Progenitor cell, Neoplasm Staging, Pharmacology, Clinical Trials as Topic, business.industry, Cell cycle, Middle Aged, Small Cell Lung Carcinoma, Haematopoiesis, 030104 developmental biology, medicine.anatomical_structure, Pyrimidines, Pharmacodynamics, 030220 oncology & carcinogenesis, Toxicity, Myelopreservation, Female, Original Article, Bone marrow, business, Chemotherapy-induced myelosuppression

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052256622fbb1819ed9ed07d56a8f61c
    https://pubmed.ncbi.nlm.nih.gov/33595690

    View record in OpenAIRE

    أضف إلى المفضلة
  9. 9
    CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

    المؤلفون: Anne Y. Lai, Konstantin H. Dragnev, Taofeek K. Owonikoko, Jessica A. Sorrentino, Jay C. Strum, Patrick J. Roberts, Jared Weiss, Zhao Yang, Julie A. Rytlewski, Rajesh K. Malik, Jill Hood

    المصدر: Journal for Immunotherapy of Cancer

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Cell cycle checkpoint, Lung Neoplasms, medicine.medical_treatment, T cell, Immunology, therapies, investigational, Lymphocyte Activation, 03 medical and health sciences, Mice, 0302 clinical medicine, Immune system, drug evaluation, preclinical, Immunology and Allergy, Medicine, Animals, Humans, Progenitor cell, Immune Checkpoint Inhibitors, Pharmacology, Clinical/Translational Cancer Immunotherapy, Chemotherapy, Tumor microenvironment, clinical trials, business.industry, phase II as topic, Cancer, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Molecular Medicine, Female, CDK4/6 Inhibition, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfb8e133ff6557650d817c053e6e13e
    https://pubmed.ncbi.nlm.nih.gov/33004541

    View record in OpenAIRE

    أضف إلى المفضلة
  10. 10
    Trial in progress: A phase 2, randomized, open-label study of trilaciclib with first-line, platinum-based chemotherapy and avelumab maintenance in untreated patients with locally advanced or metastatic urothelial carcinoma (PRESERVE 3)

    المؤلفون: Guru P. Sonpavde, Petros Grivas, Matthew I. Milowsky, Matt D. Galsky, Rajesh K. Malik, Andrew Paul Beelen

    المصدر: Journal of Clinical Oncology. 40:TPS585-TPS585

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c3b64f0b0df367a576f1353d0c7ef31b
    https://doi.org/10.1200/jco.2022.40.6_suppl.tps585

    View record in OpenAIRE

    أضف إلى المفضلة
  11. 11
    MO01.42 Myelopreservation with Trilaciclib Regardless of Risk of Chemotherapy-Induced Febrile Neutropenia and/or Anemia or Red Blood Cell Transfusions

    المؤلفون: Yili Pritchett, Maen A. Hussein, Rajesh K. Malik, I. Sinielnikov, G. Kuusk, T.A. Gersten, R. Agajanian, Antonio Calles, Shannon R. Morris, S. Gurubhagavatula, E. Thara, K. Lerro, M. Maglakelidze, O. Vynnychenko, Alexander I. Spira

    المصدر: Journal of Thoracic Oncology. 16:S33-S34

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Red blood cell, medicine.anatomical_structure, Oncology, business.industry, Anemia, Internal medicine, Chemotherapy-Induced Febrile Neutropenia, Medicine, business, medicine.disease, Gastroenterology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f50cefaa4d27be7a0e4081baff649c39
    https://doi.org/10.1016/j.jtho.2020.10.146

    View record in OpenAIRE

    أضف إلى المفضلة
  12. 12
    MO01.40 Trilaciclib has Myelopreservation Benefits in Patients with Small Cell Lung Cancer Treated with Chemotherapy, Irrespective of Age

    المؤلفون: Donald A. Richards, R. Agajanian, C. Ikpeazu, D. Berz, Joyce M Antal, M.M. Tarruella, Didier Verhoeven, Hongbin Chen, Yili Pritchett, Rajesh K. Malik, Maen A. Hussein, T. Beck

    المصدر: Journal of Thoracic Oncology. 16:S32-S33

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, business.industry, Internal medicine, medicine.medical_treatment, medicine, In patient, Non small cell, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e163017108f9b30be781f6fccb62e7c5
    https://doi.org/10.1016/j.jtho.2020.10.144

    View record in OpenAIRE

    أضف إلى المفضلة
  13. 13
    Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

    المؤلفون: Rajesh K. Malik, Petros Nikolinakos, Ralph V. Boccia, Konstantin H. Dragnev, Shannon R. Morris, Robert Hoyer, Donald A. Richards, Taofeek K. Owonikoko, A. Lowczak, Patrick J. Roberts, Vi Kien Chiu, J.T. Beck, Tibor Csoszi, Raid Aljumaily, Lowell L. Hart, I. Bulat, Maen A. Hussein, P. Sawrycki, Jessica A. Sorrentino, M. Maglakelidze, C.M. Rocha Lima, S. Adler, Jared Weiss, Zhao Yang, Joyce M Antal, S.R. Schuster, Wahid Hanna, M. Domine Gomez, Anne Y. Lai, John T. Hamm

    المصدر: Annals of Oncology

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Phases of clinical research, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, small-cell lung cancer, Myeloid Cells, Tissue Distribution, Etoposide, Aged, 80 and over, trilaciclib, Brain Neoplasms, Hematology, Middle Aged, Prognosis, Chemotherapy regimen, anemia, Survival Rate, Tolerability, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Paclitaxel, Thoracic Tumors, Neutropenia, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, CDK4/6, Humans, neutropenia, Pyrroles, myelopreservation, Lung cancer, Aged, Chemotherapy, business.industry, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Original Articles, medicine.disease, Small Cell Lung Carcinoma, Editor's Choice, 030104 developmental biology, Pyrimidines, chemistry, Cisplatin, business, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b2cc4444650e4f98df43306547bf5e
    https://pubmed.ncbi.nlm.nih.gov/31504118

    View record in OpenAIRE

    أضف إلى المفضلة
  14. 14
    Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2)

    المؤلفون: Curt Douglas Wolfgang, Wenli Tao, Hope S. Rugo, Antoinette R. Tan, Andric Zoran, Sarika Jain, Jessica A. Sorrentino, Denise A. Yardley, Shom Goel, Philippe Aftimos, Andrew P. Beelen, Rajesh K. Malik, Joyce O'Shaughnessy, Boris Milev Krastev

    المصدر: Journal of Clinical Oncology. 39:TPS1107-TPS1107

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Placebo, Gemcitabine, Carboplatin, Haematopoiesis, chemistry.chemical_compound, Second line, chemistry, Cyclin-dependent kinase, Internal medicine, medicine, biology.protein, Progenitor cell, business, Triple-negative breast cancer, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0f64609fca58a02e21d3d249a6b86e78
    https://doi.org/10.1200/jco.2021.39.15_suppl.tps1107

    View record in OpenAIRE

    أضف إلى المفضلة
  15. 15
    Academic Journal
    Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation

    المؤلفون: Alan Richardson, Rajesh K. Malik, Jeffrey D. Hildebrand, J. Thomas Parsons

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://www.pitt.edu/~biohome/Dept/pdf/817.pdf.

    وصف الملف: application/pdf

    Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.321.7448; http://www.pitt.edu/~biohome/Dept/pdf/817.pdf

    الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.321.7448
    http://www.pitt.edu/~biohome/Dept/pdf/817.pdf

    View record in BASE

    أضف إلى المفضلة
  16. 16
    Academic Journal
    Domain of Focal Adhesion Kinase (FAK) Is Rescued by Coexpression of Src or Catalytically Inactive FAK

    المؤلفون: A Richardson, R K Malik, J D Hildebr, J T Parsons, Alan Richardson, Rajesh K. Malik, Jeffrey D. Hildebrand, J. Thomas Parsons

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://mcb.asm.org/content/17/12/6906.full.pdf.

    وصف الملف: application/pdf

    Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.317.3794; http://mcb.asm.org/content/17/12/6906.full.pdf

    الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.317.3794
    http://mcb.asm.org/content/17/12/6906.full.pdf

    View record in BASE

    أضف إلى المفضلة
  17. 17
    Screening for abdominal aortic aneurysms

    المؤلفون: Zachary W. Kostun, Rajesh K. Malik

    المصدر: Clinical Imaging. 40:321-324

    مصطلحات موضوعية: Diagnostic Imaging, medicine.medical_specialty, Aortography, Cost-Benefit Analysis, 030204 cardiovascular system & hematology, 030230 surgery, Global Health, law.invention, Imaging modalities, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Risk Factors, law, medicine, Medical imaging, Humans, Mass Screening, Radiology, Nuclear Medicine and imaging, Mass screening, medicine.diagnostic_test, business.industry, Ultrasound, Ultrasonography, Doppler, medicine.disease, Abdominal aortic aneurysm, cardiovascular system, Radiology, Morbidity, Ultrasonography, Tomography, X-Ray Computed, business, Aortic Aneurysm, Abdominal

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544eb325f180d50fd301224e0a837987
    https://doi.org/10.1016/j.clinimag.2015.12.009

    View record in OpenAIRE

    أضف إلى المفضلة
  18. 18
    MO01.41 Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

    المؤلفون: Janet K. Horton, K. Nikolov, M.D. Gómez, Davorin Radosavljevic, Iveta Kudaba, Rajesh K. Malik, Jie Xiao, Jana Jaal, Janakiraman Subramanian, T. Csőszi

    المصدر: Journal of Thoracic Oncology. 16:S33

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, In patient, Non small cell, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::772c95559fb5d31fde1e9e29dfd05c1e
    https://doi.org/10.1016/j.jtho.2020.10.145

    View record in OpenAIRE

    أضف إلى المفضلة
  19. 19
    334P Lerociclib (G1T38), a continuously dosed oral CDK4/6 inhibitor, with fulvestrant in HR+/HER2- advanced breast cancer patients: Updated phase II results and dose selection

    المؤلفون: Richard D. Baird, Amy McCullough, Maia Gogiladze, Sarika Jain, H.-T. Arkenau, R Roylance, C. Murias, Adrian Crijanovschi, Andrew M Wardley, Boris Krastev, Y. Lu, Andrew P. Beelen, Curt Douglas Wolfgang, Rajesh K. Malik, Marina Maglakelidze, Iurie Bulat

    المصدر: Annals of Oncology. 31:S380

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Fulvestrant, business.industry, Advanced breast, Cancer, Hematology, medicine.disease, Internal medicine, medicine, business, medicine.drug, Dose selection

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::624cf6129def37b3addeb0736ae60dc1
    https://doi.org/10.1016/j.annonc.2020.08.436

    View record in OpenAIRE

    أضف إلى المفضلة
  20. 20
    Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer

    المؤلفون: Davey B. Daniel, Jerome H. Goldschmidt, Andric Zoran, Yili Pritchett, Rajesh K. Malik, Jared Weiss, Shannon R. Morris, Konstantin H. Dragnev

    المصدر: Journal of Clinical Oncology. 38:12096-12096

    مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer treatment, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, Non small cell, business, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cc3f77072c9a6a8ce58d1559a79f8fd8
    https://doi.org/10.1200/jco.2020.38.15_suppl.12096

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء